Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
ALI HEALTH
00241
CN Stock MarketDetailed Quotes
Zhejiang Conba Pharmaceutical (600572)
- 4.49
- -0.01-0.22%
Not Open Jan 7 15:00 CST
11.38BMarket Cap16.57P/E (TTM)
4.52High4.48Low340.68KlotVolume4.51Open4.50Prev Close153.11MTurnover1.35%Turnover Ratio18.25P/E (Static)2.53BShares4.9052wk High1.60P/B11.35BFloat Cap4.0152wk Low4.95Limit Up2.53BShs Float11.99Historical High4.05Limit Down0.89%Range %-0.97Historical Low0.15Dividend TTM4.49Avg Price210.00KlotAsk3.34%Div Yield TTM100Lot Size125.64KlotBid
Zhejiang Conba Pharmaceutical (600572) Cash Flow
All
YOY
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 5.08%4.79B | 5.72%3.27B | 3.70%1.51B | 3.67%6.63B | -7.39%4.56B | -7.61%3.1B | -8.03%1.45B | 6.31%6.4B | 20.95%4.92B | 24.28%3.35B |
| Refunds of taxes and levies | -1.75%22.32M | -8.60%15.51M | -20.28%8.16M | -9.12%34.93M | -23.94%22.71M | 59.17%16.97M | 103.38%10.24M | 5.56%38.43M | -35.28%29.86M | -72.34%10.66M |
| Cash received relating to other operating activities | -53.18%145M | 7.21%216.69M | -41.35%64.34M | 55.53%300.13M | 53.90%309.66M | 28.47%202.13M | 8.66%109.71M | -28.02%192.97M | -24.53%201.22M | -22.33%157.34M |
| Adjustment items of operating cash inflws | ---- | ---- | ---- | --0.01 | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from operating activities | 1.36%4.95B | 5.73%3.51B | 0.40%1.58B | 5.11%6.97B | -5.09%4.89B | -5.79%3.32B | -6.70%1.57B | 4.85%6.63B | 17.59%5.15B | 19.80%3.52B |
| Goods services cash paid | 0.89%1.51B | 12.43%1.07B | 3.39%406.39M | 25.71%2.23B | 10.07%1.5B | 5.13%951.83M | -9.89%393.06M | 1.13%1.78B | 9.18%1.36B | 4.76%905.37M |
| Staff behalf paid | -2.68%955.16M | -3.47%668.58M | -8.32%347.45M | 2.61%1.32B | 4.98%981.51M | 7.47%692.59M | 4.40%378.98M | 8.33%1.29B | 10.72%934.94M | 12.29%644.48M |
| All taxes paid | 10.94%491.75M | -2.19%335.9M | 0.20%165.04M | -27.34%552.98M | -31.14%443.27M | -28.18%343.43M | -36.52%164.71M | 27.04%761.05M | 39.08%643.71M | 55.00%478.21M |
| Cash paid relating to other operating activities | -2.82%1.46B | 0.81%1.03B | 7.34%510.01M | -3.02%1.85B | -2.96%1.5B | -2.84%1.02B | -12.74%475.15M | 17.44%1.9B | 18.80%1.55B | 25.52%1.05B |
| Adjustment items of operating cash outflws | ---- | ---- | ---- | --0.01 | ---- | ---- | --0.01 | ---- | ---- | ---- |
| Cash outflows from operating activities | -0.15%4.42B | 3.16%3.11B | 1.20%1.43B | 3.92%5.95B | -1.39%4.43B | -2.27%3.01B | -11.94%1.41B | 10.91%5.73B | 16.35%4.49B | 19.16%3.08B |
| Net cash flows from operating activities | 15.94%531.53M | 31.14%400.27M | -6.59%150.67M | 12.67%1.01B | -30.37%458.46M | -30.48%305.22M | 94.58%161.3M | -22.23%898.64M | 26.80%658.42M | 24.46%439.02M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | --21.08M | -96.64%21.08M | ---- | -91.06%25.96M | ---- | 119.08%626.47M | 1,211.32%25.96M | 649.85%290.28M | 626.33%291.36M | 638.75%285.95M |
| Cash received from returns on investments | -4.88%32.1M | -7.65%29.94M | --2.41M | 47.37%32.56M | 53.72%33.74M | 183.54%32.42M | ---- | -23.07%22.09M | 39.58%21.95M | -26.64%11.43M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 27.57%24.66M | 163.20%19.32M | 0.21%6.04M | -75.27%23.83M | -75.52%19.33M | -69.30%7.34M | -12.90%6.03M | -41.26%96.34M | 2,776.52%78.97M | 9,334.58%23.91M |
| Cash received relating to other investing activities | ---- | ---- | ---- | 507.15%53.35M | ---- | ---- | ---- | -84.17%8.79M | ---- | ---- |
| Adjustment iems of investing cash inflows | ---- | ---- | ---- | ---0.01 | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from investing activities | 46.65%77.83M | -89.44%70.34M | -73.59%8.45M | -67.50%135.7M | -86.47%53.07M | 107.35%666.23M | 124.70%31.98M | 45.49%417.5M | 569.59%392.28M | 489.03%321.3M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -44.15%84.08M | -44.34%57.18M | -59.59%26.02M | 38.96%290.63M | 6.48%150.54M | 22.75%102.74M | 39.64%64.38M | -28.31%209.14M | -10.86%141.38M | -14.99%83.7M |
| Cash paid to acquire investments | 246.45%607.08M | -42.18%405.01M | --502.4M | ---- | -60.62%175.23M | 57.42%700.51M | ---- | --445M | 31,284.51%445M | --445M |
| Cash paid relating to other investing activities | ---- | ---- | ---- | 7.94%56.57M | ---- | ---- | ---- | 414,441.87%52.41M | ---- | ---- |
| Cash outflows from investing activities | 112.16%691.17M | -42.46%462.2M | 720.73%528.42M | -50.86%347.2M | -44.44%325.77M | 51.93%803.25M | -87.19%64.38M | 41.86%706.56M | 60.73%586.38M | 432.08%528.7M |
| Adjustment items of net investing cash flow | ---- | ---- | ---- | --0.01 | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash flows from investing activities | -124.91%-613.33M | -185.97%-391.86M | -1,504.83%-519.98M | 26.83%-211.5M | -40.49%-272.7M | 33.93%-137.03M | 93.36%-32.4M | -36.92%-289.05M | 36.62%-194.1M | -362.77%-207.4M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | --20.56M | --7.38M | --5.53M | --48.7M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from borrowing | -68.39%232.79M | -81.64%120.78M | -89.07%43.6M | -57.24%750.27M | -34.55%736.5M | -24.69%657.74M | -38.03%398.76M | -0.30%1.75B | -4.22%1.13B | 0.07%873.38M |
| Cash inflows from financing activities | -65.60%253.35M | -80.52%128.16M | -87.68%49.13M | -54.47%798.97M | -34.55%736.5M | -24.69%657.74M | -38.03%398.76M | -0.38%1.75B | -4.22%1.13B | -0.11%873.38M |
| Borrowing repayment | -82.23%272.27M | -81.11%240.48M | -62.93%208.95M | -8.70%1.56B | 16.17%1.53B | 132.15%1.27B | 182.57%563.73M | -16.83%1.71B | -8.65%1.32B | -41.76%548.5M |
| Dividend interest payment | -32.53%394.62M | -27.27%381.45M | -65.75%2.94M | 27.04%586.89M | 28.86%584.9M | 28.13%524.44M | -41.81%8.57M | -16.30%461.96M | -10.55%453.91M | -16.97%409.29M |
| -Including:Cash payments for dividends or profit to minority shareholders | -89.83%6.44M | -88.57%1M | ---- | 51.41%63.35M | 51.41%63.35M | 51.31%8.75M | ---- | -32.09%41.84M | -28.24%41.84M | 0.79%5.78M |
| Cash payments relating to other financing activities | -94.32%31.55M | -87.51%33.47M | -95.21%5.73M | 87.37%565.68M | 399.35%555.33M | 140.99%268M | 93.88%119.55M | 285.83%301.9M | 122.64%111.21M | --111.21M |
| Cash outflows from financing activities | -73.87%698.44M | -68.27%655.4M | -68.55%217.62M | 9.70%2.71B | 41.85%2.67B | 93.24%2.07B | 150.77%691.86M | -7.91%2.47B | -5.86%1.88B | -25.49%1.07B |
| Net cash flows from financing activities | 77.01%-445.09M | 62.55%-527.24M | 42.52%-168.48M | -166.30%-1.91B | -155.14%-1.94B | -619.74%-1.41B | -179.74%-293.1M | 22.24%-719.08M | 8.19%-758.82M | 65.10%-195.63M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 304.55%2.71M | 381.20%2.37M | 3,411.71%1M | 71.15%5.11M | -166.30%-1.33M | -79.60%491.52K | 105.57%28.6K | -67.24%2.99M | -53.78%2M | 0.29%2.41M |
| Net increase in cash and cash equivalents | 70.07%-524.18M | 58.33%-516.46M | -226.96%-536.78M | -941.01%-1.11B | -498.82%-1.75B | -3,326.88%-1.24B | -328.05%-164.17M | -470.16%-106.51M | 51.98%-292.51M | 115.35%38.41M |
| Add:Begin period cash and cash equivalents | -47.67%1.22B | -47.67%1.22B | -47.67%1.22B | -4.38%2.33B | -4.38%2.33B | -4.38%2.33B | -4.38%2.33B | 1.20%2.43B | -0.87%2.43B | 1.20%2.43B |
| End period cash equivalent | 20.66%693.1M | -35.51%700.82M | -68.52%680.5M | -47.67%1.22B | -73.16%574.42M | -56.02%1.09B | -9.70%2.16B | -4.38%2.33B | 16.01%2.14B | 14.73%2.47B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
HK Tech and Internet Stocks HK Tech and Internet Stocks
Stocks of companies primarily involved in technology and internet sectors in the HK stock market. Stocks of companies primarily involved in technology and internet sectors in the HK stock market.
View More
Nancy Pelosi Portfolio Nancy Pelosi Portfolio
Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns. Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns.
Hot Topics Hot Topics
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome
牛牛課堂
Oct 13, 2025 18:05
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
Food流油
Apr 14, 2025 15:43
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"